In vivo labeling of brain capillary endothelial cells after intravenous injection of monoclonal antibodies targeting the transferrin receptor

Molecular Pharmacology

Volumn 80, Issue 1, 2011, Pages 32-39

  Paris Robidas, Sarah ^a,b   Emond, Vincent ^a,b   Tremblay, Cyntia ^a,b   Soulet, Denis ^a,b   Calon, Frédéric ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 8D3; MONOCLONAL ANTIBODY RI7; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CAPILLARY; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; ENDOTHELIUM, VASCULAR; FLUORESCENCE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; RECEPTORS, TRANSFERRIN;

EID: 79959300389     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.071027     Document Type: Article

References (40)

1. Bickel U, Kang YS, Yoshikawa T, and Pardridge WM (1994) In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibodycolloidal gold conjugate in brain capillary endothelium. J Histochem Cytochem 42:1493-1497. (Pubitemid 24338023)
2. Broadwell RD, Baker-Cairns BJ, Friden PM, Oliver C, and Villegas JC (1996) Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Exp Neurol 142:47-65. (Pubitemid 26381380)
3. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, et al. (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285-3290. (Pubitemid 41567593)
4. Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, and Pardridge WM (2000) Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res 17:266-274. (Pubitemid 30225129)
5. Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, and Lockett S (2004) Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 86:3993-4003. (Pubitemid 38780275)
6. Deane R, Bell RD, Sagare A, and Zlokovic BV (2009) Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets 8:16-30.
7. Demeule M, Poirier J, Jodoin J, Bertrand Y, Desrosiers RR, Dagenais C, Nguyen T, Lanthier J, Gabathuler R, Kennard M, et al. (2002) High transcytosis of melanotransferrin (P97) across the blood-brain barrier. J Neurochem 83:924-933. (Pubitemid 35316043)
8. Demeule M, Régina A, Ché C, Poirier J, Nguyen T, Gabathuler R, Castaigne JP, and Béliveau R (2008) Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther 324:1064-1072. (Pubitemid 351397849)
9. Dore-Duffy P and Cleary K (2011) Morphology and properties of pericytes. Methods Mol Biol 686:49-68.
10. Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, and Starzyk RM (1991) Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci USA 88:4771-4775. (Pubitemid 21914624)
11. Gabathuler R (2010) Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 37:48-57.
12. Giometto B, Bozza F, Argentiero V, Gallo P, Pagni S, Piccinno MG, and Tavolato B (1990) Transferrin receptors in rat central nervous system. An immunocytochemical study. J Neurol Sci 98:81-90. (Pubitemid 20262007)
13. Gosk S, Vermehren C, Storm G, and Moos T (2004) Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J Cereb Blood Flow Metab 24:1193-1204. (Pubitemid 39482480)
14. Hervé F, Ghinea N, and Scherrmann JM (2008) CNS delivery via adsorptive transcytosis. AAPS J 10:455-472.
15. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, and Mason DY (1984) Transferrin receptor on endothelium of brain capillaries. Nature 312:162-163. (Pubitemid 14000081)
16. Jiang C, Koyabu N, Yonemitsu Y, Shimazoe T, Watanabe S, Naito M, Tsuruo T, Ohtani H, and Sawada Y (2003) In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells. Hum Gene Ther 14:1181-1191. (Pubitemid 36930407)
17. Jiang C, Matsuo H, Koyabu N, Ohtani H, Fujimoto H, Yonemitsu Y, Kaneda Y, Narro M, Tsuruo T, and Sawada Y (2002) Transluminal gene transfer into brain capillary endothelial cells in vivo with HVJ-liposomes. J Drug Target 10:345-352. (Pubitemid 34746316)
18. Karkan D, Pfeifer C, Vitalis TZ, Arthur G, Ujiie M, Chen Q, Tsai S, Koliatis G, Gabathuler R, and Jefferies WA (2008) A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier. PLoS ONE 3:e2469.
19. Kissel K, Hamm S, Schulz M, Vecchi A, Garlanda C, and Engelhardt B (1998) Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody. Histochem Cell Biol 110:63-72. (Pubitemid 28293875)
20. Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, Lee SK, Shankar P, and Manjunath N (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448:39-43. (Pubitemid 47037001)
21. Lee HJ, Engelhardt B, Lesley J, Bickel U, and Pardridge WM (2000) Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther 292:1048-1152.
22. Markelonis GJ, Oh TH, Dion TL, Bregman BS, Pugh MA, Royal GM, Kim YC, and Hobbs SL (1988) Localization of transferrin within the developing vertebrate nervous system. Rev Neurol 144:648-655. (Pubitemid 19001910)
23. Mash DC, Pablo J, Flynn DD, Efange SM, and Weiner WJ (1990) Characterization and distribution of transferrin receptors in the rat brain. J Neurochem 55:1972-1979. (Pubitemid 120021828)
24. Moos T (1995) Age-dependent uptake and retrograde axonal transport of exogenous albumin and transferrin in rat motor neurons. Brain Res 672:14-23.
25. Moos T (1996) Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J Comp Neurol 375:675-692.
26. Moos T and Morgan EH (2001) Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat. J Neurochem 79:119-129. (Pubitemid 32946649)
27. Moos T, Rosengren Nielsen T, Skjørringe T, and Morgan EH (2007) Iron trafficking inside the brain. J Neurochem 103:1730-1740. (Pubitemid 350126643)
28. Orita T, Akimura T, Nishizaki T, Kamiryo T, Ikeyama Y, Aoki H, and Ito H (1990) Transferrin receptors in injured brain. Acta Neuropathol 79:686-688.
29. Pan W, Kastin AJ, Zankel TC, van Kerkhof P, Terasaki T, and Bu G (2004) Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier. J Cell Sci 117:5071-5078. (Pubitemid 39517522)
30. Pardridge WM (2007) Drug targeting to the brain. Pharm Res 24:1733-1744.
31. Pardridge WM, Buciak JL, and Friden PM (1991) Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther 259:66-70.
32. Pardridge WM, Eisenberg J, and Yang J (1987) Human blood-brain barrier transferrin receptor. Metabolism 36:892-895. (Pubitemid 17135085)
33. Pardridge WM, Kang YS, and Buciak JL (1994) Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm Res 11:738-746. (Pubitemid 24171772)
34. Qian ZM, Li H, Sun H, and Ho K (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54:561-587. (Pubitemid 35351196)
35. Shi N and Pardridge WM (2000) Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA 97:7567-7572. (Pubitemid 30431504)
36. Skarlatos S, Yoshikawa T, and Pardridge WM (1995) Transport of [125I]transferrin through the rat blood-brain barrier. Brain Res 683:164-171.
37. Weiss N, Miller F, Cazaubon S, and Couraud PO (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788:842-857.
38. Zhang Y, Calon F, Zhu C, Boado RJ, and Pardridge WM (2003b) Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. Hum Gene Ther 14:1-12. (Pubitemid 36126683)
39. Zhang Y, Schlachetzki F, and Pardridge WM (2003a) Global non-viral gene transfer to the primate brain following intravenous administration. Mol Ther 7:11-18. (Pubitemid 36305354)
40. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201.